P

Inventor

KESICKI EDWARD A

US54 patents
⚠️ This page may combine multiple inventors who share the name “KESICKI EDWARD A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ICOS CORP

23 patents
US7932260B2Apr 26, 2011

Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP221 citations99
US6949535B2Sep 27, 2005

Inhibitors of human phosphatidyl-inositol 3-kinase delta

ICOS CORP172 citations99
US6667300B2Dec 23, 2003

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP174 citations99
US6518277B1Feb 11, 2003

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP272 citations99
US8980901B2Mar 17, 2015

5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP39 citations98
US8586597B2Nov 19, 2013

6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP36 citations98
USRE44599ENov 12, 2013

Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP44 citations98
US9487772B2Nov 8, 2016

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP19 citations96
US8993583B2Mar 31, 2015

5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP22 citations96
US8779131B2Jul 15, 2014

6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP30 citations96
US6423710B1Jul 23, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP47 citations95
US10010550B2Jul 3, 2018

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP11 citations92
US9149477B2Oct 6, 2015

5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP17 citations92
US6716871B2Apr 6, 2004

Cyclic AMP-specific phosphodie sterase inhibitors

ICOS CORP14 citations92
US6458787B1Oct 1, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP24 citations91
US7067506B2Jun 27, 2006

Compounds useful for inhibiting Chk1

ICOS CORP31 citations90
US10695349B2Jun 30, 2020

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP2 citations84
US10398695B2Sep 3, 2019

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP5 citations84
US10336756B2Jul 2, 2019

(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP5 citations84
US7608618B2Oct 27, 2009

Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1

ICOS CORP9 citations81
US10906907B2Feb 2, 2021

Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof

ICOS CORP0 citations73
US6998416B2Feb 14, 2006

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP1 citations62
US7176229B2Feb 13, 2007

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP0 citations51

SADHU CHANCHAL

5 patents

HIBERCELL INC

5 patents

PROLINX INC

3 patents

PETRA PHARMA CORP

3 patents

FOWLER KERRY W

2 patents

ALGOMEDIX INC

2 patents

ICOS

1 patent

LUITPOLD PHARM INC

1 patent

DUNCAN IAIN W

1 patent

HALBROOK JAMES W

1 patent

DIAZ FRANK

1 patent

BIO AFFINITY SYSTEMS

1 patent

Neumedics

1 patent

Showing the top 50 of 54 patents by PatentIndex Score.